Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
ConocoPhillips
COP
|
+$3.33B |
| 2 |
Merck
MRK
|
+$2.61B |
| 3 |
Schlumberger
SLB
|
+$1.65B |
| 4 |
Target
TGT
|
+$1.34B |
| 5 |
General Mills
GIS
|
+$926M |
Top Sells
| 1 |
Pfizer
PFE
|
+$2.72B |
| 2 |
Blackrock
BLK
|
+$2.48B |
| 3 |
US Bancorp
USB
|
+$1.68B |
| 4 |
M&T Bank
MTB
|
+$762M |
| 5 |
Huntington Bancshares
HBAN
|
+$554M |
Sector Composition
| 1 | Technology | 21.5% |
| 2 | Financials | 11.88% |
| 3 | Healthcare | 10.59% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AISP
3326
Airship AI Holdings
AISP
$138M
| $114K | ﹤0.01% |
29,507
| – | – |
|
3327
X4 Pharmaceuticals
XFOR
$73.6M
| $114K | ﹤0.01% |
16,051
+1,444
| +10% | +$10.2K |
|
|
BLUE
3328
DELISTED
bluebird bio
BLUE
| $113K | ﹤0.01% |
23,235
-4,417
| -16% | -$21.6K |
|
3329
Invivyd
IVVD
$255M
| $113K | ﹤0.01% |
186,680
| – | – |
|
3330
Pyxis Oncology
PYXS
$113M
| $113K | ﹤0.01% |
115,237
-14,524
| -11% | -$14.2K |
|
|
FBLA
3331
FB Bancorp, Inc. Common Stock
FBLA
$219M
| $113K | ﹤0.01% |
10,000
| – | – |
|
3332
Citizens
CIA
$263M
| $112K | ﹤0.01% |
24,606
| – | – |
|
|
INZY
3333
DELISTED
Inozyme Pharma
INZY
| $111K | ﹤0.01% |
122,290
-20,868
| -15% | -$19K |
|
3334
HilleVax
HLVX
$105M
| $110K | ﹤0.01% |
75,937
+341
| +0.5% | +$494 |
|
3335
Golden Matrix Group
GMGI
$148M
| $109K | ﹤0.01% |
55,298
| – | – |
|
3336
Shattuck Labs
STTK
$96.3M
| $108K | ﹤0.01% |
114,139
| – | – |
|
3337
Aligos Therapeutics
ALGS
$77.2M
| $105K | ﹤0.01% |
12,686
-1,600
| -11% | -$13.2K |
|
3338
MediciNova
MNOV
$61.8M
| $104K | ﹤0.01% |
71,506
| – | – |
|
3339
Soho House & Co
SHCO
$1.73B
| $104K | ﹤0.01% |
16,810
| – | – |
|
3340
Myomo
MYO
$35.9M
| $103K | ﹤0.01% |
21,495
| – | – |
|
3341
Cibus
CBUS
$68.3M
| $103K | ﹤0.01% |
55,142
+13,583
| +33% | +$25.4K |
|
|
MODV
3342
DELISTED
ModivCare
MODV
| $102K | ﹤0.01% |
77,824
-34,219
| -31% | -$45K |
|
3343
Eledon Pharmaceuticals
ELDN
$160M
| $102K | ﹤0.01% |
29,987
| – | – |
|
3344
Forafric Global
AFRI
$222M
| $101K | ﹤0.01% |
11,701
-3,440
| -23% | -$29.6K |
|
3345
Nautilus Biotechnolgy
NAUT
$84.6M
| $99.4K | ﹤0.01% |
115,418
+187
| +0.2% | +$161 |
|
3346
Vuzix
VUZI
$178M
| $99.3K | ﹤0.01% |
48,683
| – | – |
|
3347
Skye Bioscience
SKYE
$128M
| $99.2K | ﹤0.01% |
62,363
| – | – |
|
3348
Mersana Therapeutics
MRSN
$35.1M
| $96.6K | ﹤0.01% |
11,225
-1,280
| -10% | -$11K |
|
3349
DLH Holdings
DLHC
$82.9M
| $96.4K | ﹤0.01% |
23,811
+23
| +0.1% | +$93 |
|
3350
Western New England Bancorp
WNEB
$251M
| $96.2K | ﹤0.01% |
10,349
| – | – |
|